Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis

This review found ACE inhibitor/angiotensin receptor blocker use did not increase the risk of all-cause mortality (13 studies; n=21,178) and was not related to an increased risk of severe disease (13 studies; n=12,848); although there was significant statistical heterogeneity.

Thorax